Nature Medicine, Published online: 14 April 2026; doi:10.1038/s41591-026-04317-6
A first-in-human phase 1 trial shows that intravitreal photoswitch therapy can be administered safely in advanced retinitis pigmentosa, with exploratory signals compatible with light responsiveness following treatment.
